Results 121 to 130 of about 8,935 (297)
ABSTRACT Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia encountered in clinical practice. Its incidence increases significantly with age and has become a major global public health issue. Although research into the mechanisms of AF has spanned over a century‐ranging from the reentry theory to the rotor hypothesis‐none of these
Xin Chu +4 more
wiley +1 more source
A case report on the ‘cobra twist’ technique: covering the posterior lobe of the left atrial appendage during percutaneous closure in a patient with challenging anatomy [PDF]
Masanori Yamamoto +3 more
openalex +1 more source
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Edwin Cuperus +7 more
wiley +1 more source
ABSTRACT Introduction There is limited data regarding the use of pulsed‐field ablation (PFA) for mitral isthmus (MI) ablation in patients with non‐paroxysmal atrial fibrillation (AF). Our aim was to assess the acute efficacy of MI ablation using a pentaspline PFA catheter with two different ablation settings.
Josef Hornof +13 more
wiley +1 more source
Holmes D.R. Jr, Doshi S.K., Kar S., et al. Left Atrial Appendage Closure as an Alternative to Warfarin for Stroke Prevention in Atrial Fibrillation: A PatientLevel MetaAnalysis // J. Am. Coll. Cardiol. – 2015. – Vol. 65. – P. 2614–2623.
doaj
ABSTRACT Introduction Approval timelines for ablation catheters differ across major markets, potentially delaying clinical access. This study aimed to quantify approval lags for contemporary ablation catheters across the EU, the US, and Japan. Methods We retrospectively identified therapeutic ablation catheters with documented approval dates in the ...
Gaku Oguri +2 more
wiley +1 more source
ABSTRACT Background AVEIR DR, an industry‐first dual‐chamber leadless pacemaker (LP), provides continuous atrioventricular synchrony through implant‐to‐implant (i2i) communication between atrial and ventricular LP devices. It is important to evaluate the early real‐world comparative safety of AVEIR DR LP.
Monica Lo +10 more
wiley +1 more source
ABSTRACT Aims/Introduction While treatment for diabetic polyneuropathy (DPN) is still developing, progress has stagnated. The alignment between pathological neurodegeneration in DPN and patients' subjective symptoms is often low, yet these symptoms are frequently used for diagnosis.
Tatsuhito Himeno +14 more
wiley +1 more source
ABSTRACT Background The impact of COVID‐19 infection on diabetic ketoacidosis (DKA) outcomes remains incompletely characterized at a national level. Methods We analyzed adult DKA hospitalizations in the United States from the 2020–2021 National Inpatient Sample.
Jia Ee Chia +4 more
wiley +1 more source

